Intracranial Activity of Cabozantinib in MET Exon 14-Positive NSCLC with Brain Metastases

This report provides the first detailed description of brain metastases in MET exon 14-positive NSCLC and provides preliminary support for the intracranial activity of cabozantinib. Prospective study is warranted and needed to refine the management of intracranial disease in MET exon 14-positive NSCLC.